Top Tweets for #neogenomics
#NeoGenomics has expanded its partnership with Indica Labs, a global leader in AI-powered digital pathology: https://t.co/nx7urwlnLy.
Warren Stone, #NeoGenomics' current President and COO, has been appointed CEO and a member of the Board, effective January 4, 2027.
Tony Zook, current CEO and member of the Board, will transition to Executive Chair on January 4, 2027.
#BreastCancerAwarenessMonth begins today🎗️ All month long, we will be sharing education and resources, highlighting our testing solutions, and more.
#BreastCancerAwarenessMonth #BreastCancerAwareness2025 #CancerTesting #Oncology #NeoGenomics
RaDaR® ST provides clear, actionable answers: https://t.co/uMhtb5Vj8d.
#NeoGenomics #RaDaRST #PrecisionOncology #MRD
Wearing green for #MentalHealthAwareness 💚 At #NeoGenomics, we believe supporting mental health and well-being is just as important as supporting physical health. If you're interested in an organization committed to supporting emotional well-being, visit https://t.co/HDQFzaSvdJ.
As the NSCLC treatment landscape evolves, actionable biomarkers like c‑MET play an increasingly critical role. The c‑MET CDx for NSCLC IHC supports precision‑driven testing to guide targeted therapy decisions: https://t.co/ssIMzlXA19
#NeoGenomics #NSCLC #PrecisionMedicine #cMET
To obtain confidence in every result, and simplify complex myeloid cases, #NeoGenomics provides clarity: https://t.co/IbVJDDasYF
Neo Comprehensive – Myeloid Disorders uses DNA and RNA NGS to uncover actionable insights for MDS and CMML.
#MDS #CMML #Myeloid #HematologicalCancer
𝐑𝐞𝐚𝐥-𝐭𝐢𝐦𝐞 𝐚𝐥𝐞𝐫𝐭𝐬. 𝐒𝐦𝐚𝐫𝐭𝐞𝐫 𝐝𝐞𝐜𝐢𝐬𝐢𝐨𝐧𝐬. Stay ahead with NeoGenomics’ data triggers—patient and physician-level alerts that keep your strategy proactive, not reactive: https://t.co/wAp0tYjktg.
#OncologyInsights #DataTriggers #NeoGenomics
RaDaR® ST��s coverage helps ensure more patients can benefit from MRD-guided insights while giving your practice greater certainty and smoother billing workflows: https://t.co/EHCkIeKjxe.
#NeoGenomics #RaDaRST #PrecisionOncology #MRD
The #NeoGenomics oncology data solutions team is excited to be at #AACR26! Schedule a meeting with them here: https://t.co/5AMNT2thSe and learn more below about how multimodal data is driving the next era of translational research.
RaDaR® ST delivers intuitive, easy-to-interpret reports that translate complex molecular data into clear clinical guidance: https://t.co/2H4Bvzr6OG.
#NeoGenomics #RaDaRST #PrecisionOncology #MRD
PanTracer Pro ensures you have the insights tailored to your patient’s tumor type and clinical context needed to guide precision oncology: https://t.co/OKEHv4vmZj
#Oncology #PanTracerPro #NeoGenomics #CancerTesting
AI is transforming oncology. Explore how digital pathology and AI are reshaping screening and diagnosis in our new white paper: https://t.co/wAp0tYjktg
#AIDigitalPathology #PrecisionOncology #NeoGenomics
New white paper! From Data to Decision: Biomarkers Driving Precision Medicine: https://t.co/wAp0tYjktg. Gastric cancer remains the 4th leading cause of cancer-related death worldwide, but #biomarker-driven therapies are changing the game.
#OncologyData #NeoGenomics
We can’t wait to meet you! Visit #NeoGenomics at booth #639 at the USCAP 115th Annual Meeting to explore innovations driving precision oncology forward. #USCAP2026 #Pathology #OncologyDiagnostics
Wherever the signal starts, you can find it with RaDaR ST: https://t.co/OgWowWlT4t
Its highly sensitive MRD technology detects tumor DNA, long before imaging, revealing the earliest signs of recurrence and supports timely, confident decisions.
#NeoGenomics #PrecisionOncology
RaDaR® ST minimizes false positives and supports precise, timely care decisions: https://t.co/OgWowWlT4t.
#NeoGenomics #RaDaRST #PrecisionOncology #MRD
.
.
.
*Detection down to 1 part per million (ppm) under study-specific conditions
RaDaR® ST is supported by a growing foundation of clinical evidence. https://t.co/OgWowWlT4t.
#NeoGenomics #RaDaRST #PrecisionOncology #MRD
RaDaR® ST identifies the unique tumor profile of each patient to provide clear answers: https://t.co/OgWowWlT4t.
#NeoGenomics #RaDaRST #PrecisionOncology #MRD
Neo Comprehensive® – Myeloid Disorders, a CGP NGS assay, delivers clear and precise results for myeloid disorders, including MDS and CMML, helping clinicians make confident decisions. https://t.co/0tPKXGAxTd
#NeoGenomics #CancerTesting #OncologyInsights
Last Seen Hashtags on Sotwe
okullar
Seen from Turkey
Epping
Seen from United States
anxiouspanda
Seen from Netherlands
babyalien
Seen from Turkey
17octobre
Seen from France
somali wasmo
Seen from Kenya
islamabadshemale
Seen from Pakistan
gaysmp
Seen from Indonesia
minichat() + filter:native_video
Seen from Germany
MNWO
Seen from Sweden
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
241.5M followers
Barack Obama
@barackobama
118.9M followers
Cristiano Ronaldo
@cristiano
114.6M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.3M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90.1M followers
Taylor Swift
@taylorswift13
84M followers
Lady Gaga
@ladygaga
75.5M followers
Virat Kohli
@imvkohli
73.5M followers
Kim Kardashian
@kimkardashian
70.9M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.5M followers
Bill Gates
@billgates
65.3M followers
Selena Gomez
@selenagomez
63.1M followers
The Ellen Show
@theellenshow
62.2M followers
CNN
@cnn
61.7M followers
X
@x
60.7M followers